- Home
- SVII vs LUNG Comparison
SVII vs LUNG Comparison
Compare SVII & LUNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SVII
- LUNG
- Stock Information
- Founded
- SVII 2021
- LUNG 1995
- Country
- SVII United States
- LUNG United States
- Employees
- SVII N/A
- LUNG N/A
- Industry
- SVII Blank Checks
- LUNG Industrial Specialties
- Sector
- SVII Finance
- LUNG Health Care
- Exchange
- SVII Nasdaq
- LUNG Nasdaq
- Market Cap
- SVII 116.6M
- LUNG 124.0M
- IPO Year
- SVII 2022
- LUNG 2020
- Fundamental
- Price
- SVII $11.75
- LUNG $2.58
- Analyst Decision
- SVII
- LUNG Buy
- Analyst Count
- SVII 0
- LUNG 6
- Target Price
- SVII N/A
- LUNG $11.53
- AVG Volume (30 Days)
- SVII 5.0K
- LUNG 360.8K
- Earning Date
- SVII 01-01-0001
- LUNG 07-30-2025
- Dividend Yield
- SVII N/A
- LUNG N/A
- EPS Growth
- SVII N/A
- LUNG N/A
- EPS
- SVII 0.25
- LUNG N/A
- Revenue
- SVII N/A
- LUNG $87,473,000.00
- Revenue This Year
- SVII N/A
- LUNG $18.02
- Revenue Next Year
- SVII N/A
- LUNG $18.17
- P/E Ratio
- SVII $47.30
- LUNG N/A
- Revenue Growth
- SVII N/A
- LUNG 19.84
- 52 Week Low
- SVII $11.06
- LUNG $2.50
- 52 Week High
- SVII $11.90
- LUNG $9.37
- Technical
- Relative Strength Index (RSI)
- SVII 54.77
- LUNG 35.17
- Support Level
- SVII $11.50
- LUNG $2.50
- Resistance Level
- SVII $11.78
- LUNG $2.80
- Average True Range (ATR)
- SVII 0.08
- LUNG 0.18
- MACD
- SVII -0.00
- LUNG 0.01
- Stochastic Oscillator
- SVII 78.86
- LUNG 13.82
About SVII Spring Valley Acquisition Corp. II
Spring Valley Acquisition Corp II is a blank check company.
About LUNG Pulmonx Corporation
Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.